Your browser doesn't support javascript.
loading
Clinical, demographic, and epidemiologic characteristics of hepatitis B virus-infected patients at a tertiary public hospital in Presidente Prudente, State of São Paulo, Brazil
Prestes-Carneiro, Luiz Euribel; Vieira, Jessyka Thaiza Menezes; Isaac, Luiza Bellintani; Portelinha Filho, Alexandre Martins.
  • Prestes-Carneiro, Luiz Euribel; Hospital Regional de Presidente Prudente. Departamento de Doenças Infecciosas e Departamento de Clínica Médica. Presidente Prudente. BR
  • Vieira, Jessyka Thaiza Menezes; Hospital Regional de Presidente Prudente. Departamento de Doenças Infecciosas e Departamento de Clínica Médica. Presidente Prudente. BR
  • Isaac, Luiza Bellintani; Hospital Regional de Presidente Prudente. Departamento de Doenças Infecciosas e Departamento de Clínica Médica. Presidente Prudente. BR
  • Portelinha Filho, Alexandre Martins; Hospital Regional de Presidente Prudente. Departamento de Doenças Infecciosas e Departamento de Clínica Médica. Presidente Prudente. BR
Rev. Soc. Bras. Med. Trop ; 49(1): 24-28, Jan.-Feb. 2016. tab
Article in English | LILACS | ID: lil-776535
ABSTRACT
Abstract: INTRODUCTION: Few studies have addressed the primary characteristics of patients infected with hepatitis B virus (HBV) in the general population, especially those living in small- and medium-sized cities in Brazil. We aimed to determine the clinical, demographic, and epidemiologic characteristics of patients diagnosed with HBV who were followed up at an infectious diseases clinic of a public hospital in State of São Paulo, Brazil. METHODS: Medical records of patients aged >18 years and diagnosed with HBV infection between January 2000 and December 2013 were reviewed. RESULTS: Seventy-five patients were enrolled with male-female main infection-associated risk factors; 9 (12%) were co-infected with human immunodeficiency virus (HIV), 5 (6.7%) with hepatitis C virus (HCV), and 3 (4%) were co-infected with both HIV and HCV. Antiviral HBV therapy was applied in 21 (28%) patients and tenofovir monotherapy was the most prescribed medication. After approximately 2 years of antiviral treatment, the HBV-DNA viral load was undetectable in 12 (92.3%) patients and lower levels of alanine aminotransferase were found in these patients. CONCLUSIONS: Over a 13-year interval, very few individuals infected with HBV were identified, highlighting the barriers for caring for patients with HBV in developing countries. New measures need to be implemented to complement curative practices.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Hepatitis B Type of study: Diagnostic study / Etiology study / Incidence study / Observational study / Prognostic study / Risk factors Limits: Adult / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Rev. Soc. Bras. Med. Trop Journal subject: Tropical Medicine Year: 2016 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital Regional de Presidente Prudente/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Hepatitis B Type of study: Diagnostic study / Etiology study / Incidence study / Observational study / Prognostic study / Risk factors Limits: Adult / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Rev. Soc. Bras. Med. Trop Journal subject: Tropical Medicine Year: 2016 Type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital Regional de Presidente Prudente/BR